Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Oncology

Lung/Thoracic Oncology

Randomized phase III study of pemetrexed plus cisplatin vs vinorelbine plus cisplatin for completely resected stage II to IIIA nonsquamous non–small-cell lung cancer

Journal of Clinical Oncology | Jul 01, 2020 Lung/Thoracic Oncology

Association between diabetes mellitus and lung cancer: Meta‐analysis

European Journal of Clinical Investigation | Jul 01, 2020 Lung/Thoracic Oncology

Imaging features and prognostic value of ¹⁸F-FDG PET/CT detection of soft-tissue metastasis from lung cancer: A retrospective study

BMC Cancer | Jul 01, 2020 Lung/Thoracic Oncology

Efficacy of traditional Chinese Medicine combined with chemotherapy in patients with non-small cell lung cancer (NSCLC): A meta-analysis of randomized clinical trials

Supportive Care in Cancer | Jul 01, 2020 Lung/Thoracic Oncology

Association of mental health treatment with outcomes for US veterans diagnosed with non–small cell lung cancer

JAMA | Jun 10, 2020 Lung/Thoracic Oncology

Correlation between the expression of folate receptor alpha (FRα) and clinicopathological features in patients with lung adenocarcinoma

Lung Cancer | Jun 08, 2020 Lung/Thoracic Oncology

First-in-human, multicenter, phase I dose-escalation and expansion study of anti-mesothelin antibody–drug conjugate anetumab ravtansine in advanced or metastatic solid tumors

Journal of Clinical Oncology | Jun 03, 2020 Lung/Thoracic Oncology

FHIT^low/pHER2^high signature in non‐small cell lung cancer is predictive of anti‐HER2 molecule efficacy

Journal of Pathology | Apr 07, 2020 Lung/Thoracic Oncology

Typical and atypical carcinoid tumors of the lung: A clinicopathological correlation of 783 cases with emphasis on histological features

Human Pathology | Apr 06, 2020 Lung/Thoracic Oncology

Clearing of circulating tumour DNA predicts clinical response to osimertinib in EGFR mutated lung cancer patients

Lung Cancer | Mar 24, 2020 Lung/Thoracic Oncology

« Prev 1 … 50 51 52 53 54 … 149 Next »

Randomized phase III study of pemetrexed plus cisplatin vs vinorelbine plus cisplatin for completely resected stage II to IIIA nonsquamous non–small-cell lung cancer

Association between diabetes mellitus and lung cancer: Meta‐analysis

Imaging features and prognostic value of ¹⁸F-FDG PET/CT detection of soft-tissue metastasis from lung cancer: A retrospective study

Efficacy of traditional Chinese Medicine combined with chemotherapy in patients with non-small cell lung cancer (NSCLC): A meta-analysis of randomized clinical trials

Association of mental health treatment with outcomes for US veterans diagnosed with non–small cell lung cancer

Correlation between the expression of folate receptor alpha (FRα) and clinicopathological features in patients with lung adenocarcinoma

First-in-human, multicenter, phase I dose-escalation and expansion study of anti-mesothelin antibody–drug conjugate anetumab ravtansine in advanced or metastatic solid tumors

FHIT^low/pHER2^high signature in non‐small cell lung cancer is predictive of anti‐HER2 molecule efficacy

Typical and atypical carcinoid tumors of the lung: A clinicopathological correlation of 783 cases with emphasis on histological features

Clearing of circulating tumour DNA predicts clinical response to osimertinib in EGFR mutated lung cancer patients

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

Gut Health Disorders and its Management

Awareness for COPD: MCQ challenge

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Randomized phase III study of pemetrexed plus cisplatin vs vinorelbine plus cisplatin for completely resected stage II to IIIA nonsquamous non–small-cell lung cancer

Association between diabetes mellitus and lung cancer: Meta‐analysis

Imaging features and prognostic value of 18F-FDG PET/CT detection of soft-tissue metastasis from lung cancer: A retrospective study

Efficacy of traditional Chinese Medicine combined with chemotherapy in patients with non-small cell lung cancer (NSCLC): A meta-analysis of randomized clinical trials

Association of mental health treatment with outcomes for US veterans diagnosed with non–small cell lung cancer

Correlation between the expression of folate receptor alpha (FRα) and clinicopathological features in patients with lung adenocarcinoma

First-in-human, multicenter, phase I dose-escalation and expansion study of anti-mesothelin antibody–drug conjugate anetumab ravtansine in advanced or metastatic solid tumors

FHITlow/pHER2high signature in non‐small cell lung cancer is predictive of anti‐HER2 molecule efficacy

Typical and atypical carcinoid tumors of the lung: A clinicopathological correlation of 783 cases with emphasis on histological features

Clearing of circulating tumour DNA predicts clinical response to osimertinib in EGFR mutated lung cancer patients

BRI or BMI: What is More Efficient?

Enhancing Conventional Diabetes Management with Lifestyle and Nutritional Interventions

Gut Health Disorders and its Management

Awareness for COPD: MCQ challenge

Addressing Sleep Disorders with Integrative Solutions: From Pharmaceuticals to Natural Remedies

Select Specialty

Select Topic

Imaging features and prognostic value of ¹⁸F-FDG PET/CT detection of soft-tissue metastasis from lung cancer: A retrospective study

FHIT^low/pHER2^high signature in non‐small cell lung cancer is predictive of anti‐HER2 molecule efficacy